Back to Authors

Greene, Eddie L.

A5109110792 | I1330342723

Mayo Clinic

Mayo Clinic

Citations 18

Big Topics for Diabetes Care in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology

Diabetes Care | June 22, 2018 | Volume: 41 | Issue: 7 | Pages: 1327-1329

10.2337/dci18-0035 | PMID 29934474

P1218Incidence and Risk Factors for Renal Dysfunction after Direct Current Cardioversion of Atrial Fibrillation

EP Europace | March 19, 2018 | Volume: 20 | Issue: suppl_1 | Pages: i239-i239

10.1093/europace/euy015.700

Diabetes Care: “Taking It to the Limit One More Time”

Diabetes Care | December 20, 2016 | Volume: 40 | Issue: 1 | Pages: 3-6

10.2337/dc16-2326 | PMID 27999000

Diabetes Care: “Lagniappe” and “Seeing Is Believing”!

Diabetes Care | June 23, 2016 | Volume: 39 | Issue: 7 | Pages: 1069-1071

10.2337/dc16-0891 | PMID 27631957

Building Momentum: Taking on the Real “Issues” of Diabetes Care!

Diabetes Care | December 23, 2015 | Volume: 39 | Issue: 1 | Pages: 10-12

10.2337/dc15-2315 | PMID 27606379

Status of Diabetes Care: New Challenges, New Concepts, New Measures—Focusing on the Future!

Diabetes Care | June 23, 2015 | Volume: 38 | Issue: 7 | Pages: 1177-1180

10.2337/dc15-0875 | PMID 26312261

Status of Diabetes Care: “It Just Doesn’t Get Any Better . . . or Does It?”

Diabetes Care | June 24, 2014 | Volume: 37 | Issue: 7 | Pages: 1782-1785

10.2337/dc14-1073 | PMID 25093231

Clinical Outcomes in Patients With Renal Artery Stenosis Treated With Stent Placement With Embolic Protection Compared With Those Treated With Stent Alone

Vascular and Endovascular Surgery | June 12, 2012 | Volume: 46 | Issue: 6 | Pages: 447-454

10.1177/1538574412449911 | PMID 22692467

Purpose: To compare the clinical outcomes in patients with chronic renal insufficiency (CRI) and renal artery stenosis (RAS) following renal artery (RA) stent placement with and without embolic protection device (EPD) usage. Materials and Methods: Eighteen patients who had RA stent placement with EPD were matched to control patients (RA stent only). Blood pressure, number of hypertensive medications, and estimated glomerular filtration rate (eGFR) at 3 months before the procedure and after 12 months were determined. An increase of ≥ 20% in eGFR at 12 months from baseline was defined as “improvement,” decrease of ≥20% as “deterioration,” and an eGFR change between those values as “stabilization” at 12 months. Results: At 12 months, stage 4 patients treated with EPD had significantly higher eGFR than controls ( P = .01). There was no statistical difference in blood pressure outcomes between the 2 groups. Conclusions: Patients with stage 4 CRI did significantly better with EPD than those treated without it.